Uncategorised - European Medical Journal

Scientists Identify Genetic Variants That Drive Cancer Risk and Growth

Researchers uncover genetic variants that drive cancer risk, revealing new therapeutic targets and refining genetic screening strategies.

The Second Brain: Transforming Gut Healing: Part 2

In this second part of the podcast, Jonathan welcomes back Douglas Drossman, pioneer in disorders of gut-brain interaction.

STI Surge in Europe Sparks Public Health Concern

The ECDC’s Annual Epidemiological Reports analysed surveillance data from 29 EU/EEA countries, tracking trends in gonorrhoea, syphilis, and chlamydia.

Coeliac Disease Risk Drops with High-Fibre Diet in Infants

A new study suggests that infants who consume a high-fibre diet before their first birthday may have a significantly lower risk of developing celiac disease.

Which Treatment for Basal Cell Carcinoma is More Effective?

After five years, the probability of remaining free from treatment failure was 77.8% for patients who underwent superficial curettage.

Long-Term Study on Effects of IVF on Cancer Risk

A long-term study of assisted reproductive technology (ART) has found no increased risk of endometrial cancer, addressing concerns about the potential long-term effects of fertility treatments.

A Roadmap for Clear Skin

Notable recent additions to dermatologists’ acne toolkit include newer dual and triple combination therapies, as well as agents with…

New Clinical Guidelines for Managing Central Airway Obstruction

Clinical practice guidelines providing critical recommendations for managing central airway obstruction (CAO), a condition linked to poor prognosis in both malignant and nonmalignant airway diseases, have recently been published.

What Are Best Next Steps After JAKi Failure?

For patients with rheumatoid arthritis (RA) with an inadequate response to Janus kinase inhibitors (JAKi), new research suggests that cycling to another JAKi may be more effective than switching to a biologic disease-modifying anti-rheumatic drug (bDMARD).

Statins Linked to Better Immune Checkpoint Inhibitor Outcomes

A recent meta-analysis suggests that statin use is associated with improved survival outcomes in patients with cancer undergoing immune checkpoint inhibitor (ICI) therapy.